Team Chriso Foundation for Cystic Fibrosis

07/03/2024

The AEROBIKA™ is a drug free, portable device which is clinically proven to assist in the clearance of excess mucus from your lungs.

OPEP treatment may be required for lung diseases such as COPD, Bronchiectasis, Cystic Fibrosis and/or lung infections where excess mucus is produced.

The AEROBIKA™ is the only OPEP device which can be paired with a nebuliser for combination therapy.

Benefits include:
✅ Drug-free, handheld device
✅ Opens airways
✅ Thins and loosens mucus
✅ Complements inhaled medications
✅ Inhale and exhale without removing your mouth
✅ Can be used seated, standing or even laying down

For more information, visit our website au.healthcare.airliquide.com/aerobika

29/02/2024

29/11/2023

This is awesome 🙌🏻 💕

👨‍🍼 Beginning from 12 weeks of pregnancy, and through to 6 months after birth, expectant fathers and new fathers can sign up to SMS4dads for FREE.

Once registered, you will receive three text messages a week to help them make the transition to fatherhood.

Sign up today. https://www.sms4dads.com.au/

29/11/2023

Anyone in Nth QLD that can help Ronald McDonald House Charities North Australia support families over Christmas please click the link below 🙏🫶🏻🎅🏼

This festive season, 25 families will call Ronald McDonald House Townsville home. Please help us bring the magic of Christmas to these families by supporting our Christmas Wishlist or donating at
https://nafundraising.rmhc.org.au/rmhc-north-australia-christmas-giving 🎅🎄🎁

29/11/2023

You are invited to participate in a research survey focusing on the impact of Trikafta on the treatment regimens of individuals living with cystic fibrosis (CF).

This research aims to explore the changes in medication and other forms of treatment that individuals with CF have experienced since initiating Trikafta. By participating in this survey, you play a crucial role in advancing knowledge in this area.

Inclusion and exclusion criteria: You are eligible to participate in this study if you are over the age of 16 and are currently using Trikafta.

What does this research involve? The research involves the completion of an anonymous online survey. No identifying information is required. This survey contains 12 questions and will take approximately 5 -10 minutes to complete. You will then be invited to do an interview via Zoom to further elaborate on these questions.

To learn more, please follow the link: https://bit.ly/3R3jXp8

03/10/2023

With just one week left in Layne's incredible journey, he continues to champion the cause of raising awareness and much-needed funds for the entire CF community and Cystic Fibrosis Australia.

Please read our most recent Communique for all the updates on Layne's momentous feat.

Read here: https://bit.ly/48oNeCy

22/09/2023

09/08/2023

CFTR modulator therapies enhance the ability of immune macrophage cells to kill bacteria, independent of CF-causing defects, a study finds.

08/08/2023

Promoting Research on CF and Motherhood

A study is being carried out by the University of Sydney, focusing on the experiences of women with cystic fibrosis who have had a baby.

To provide your input, please follow the link: https://redcap.sydney.edu.au/surveys/?s=JFJ7KD4MNXN8KCTK

30/07/2023

Played their hearts out 💕 & came away runners up with the sliver medal, what a great effort ✨

28/07/2023

Day 2 for Ayden at the QLD All Schools event on the Sunshine Coast. Having the best time with his teammates 🥰